Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112

Liwei Chen, Daniele Pernazza, Latanya M. Scott, Harshani R. Lawrence, Yuan Ren, Yunting Luo, Xin Wu, Shen-shu Sung, Wayne C. Guida, Said M. Sebti, Nicholas J. Lawrence, Jie Wu

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

The protein tyrosine phosphatase (PTP) Shp2 (PTPN11) is an attractive target for anticancer drug discovery because it mediates growth factor signaling and its gain-of-function mutants are causally linked to leukemias. We previously synthesized SPI-112 from a lead compound of Shp2 inhibitor, NSC-117199. In this study, we demonstrated that SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2. Like some other compounds in the PTP inhibitor discovery efforts, SPI-112 was not cell permeable, precluding its use in biological studies. To overcome the cell permeation issue, we prepared a methyl ester SPI-112 analog (SPI-112Me) that is predicted to be hydrolyzed to SPI-112 upon entry into cells. Fluorescence uptake assay and confocal imaging suggested that SPI-112Me was taken up by cells. Incubation of cells with SPI-112Me inhibited epidermal growth factor (EGF)-stimulated Shp2 PTP activity and Shp2-mediated paxillin dephosphorylation, Erk1/2 activation, and cell migration. SPI-112Me treatment also inhibited Erk1/2 activation by a Gab1-Shp2 chimera. Treatment of Shp2E76K mutant-transformed TF-1 myeloid cells with SPI-112Me resulted in inhibition of Shp2E76K-dependent cell survival, which is associated with inhibition of Shp2E76K PTP activity, Shp2E76K-induced Erk1/2 activation, and Bcl-XL expression. Furthermore, SPI-112Me enhanced interferon-γ (IFN-γ)-stimulated STAT1 tyrosine phosphorylation, ISRE-luciferase reporter activity, p21 expression, and the anti-proliferative effect. Thus, the SPI-112 methyl ester analog was able to inhibit cellular Shp2 PTP activity.

Original languageEnglish (US)
Pages (from-to)801-810
Number of pages10
JournalBiochemical Pharmacology
Volume80
Issue number6
DOIs
StatePublished - Sep 1 2010

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Pharmacology

Fingerprint Dive into the research topics of 'Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112'. Together they form a unique fingerprint.

  • Cite this

    Chen, L., Pernazza, D., Scott, L. M., Lawrence, H. R., Ren, Y., Luo, Y., Wu, X., Sung, S., Guida, W. C., Sebti, S. M., Lawrence, N. J., & Wu, J. (2010). Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112. Biochemical Pharmacology, 80(6), 801-810. https://doi.org/10.1016/j.bcp.2010.05.019